Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000197533 | SCV000249977 | uncertain significance | not provided | 2024-04-15 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Illumina Laboratory Services, |
RCV000294359 | SCV000425628 | uncertain significance | Ehlers-Danlos syndrome type 7A | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002229091 | SCV000631593 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2023-10-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315571 | SCV000738690 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-06-21 | criteria provided, single submitter | clinical testing | The p.R1060W variant (also known as c.3178C>T), located in coding exon 45 of the COL5A2 gene, results from a C to T substitution at nucleotide position 3178. The arginine at codon 1060 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |
Centre for Mendelian Genomics, |
RCV001197291 | SCV001367941 | uncertain significance | Ehlers-Danlos syndrome, classic type, 2 | 2019-03-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3. |
Mayo Clinic Laboratories, |
RCV000197533 | SCV001714076 | uncertain significance | not provided | 2019-09-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001197291 | SCV002779720 | uncertain significance | Ehlers-Danlos syndrome, classic type, 2 | 2021-11-12 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV000197533 | SCV005196629 | uncertain significance | not provided | 2022-05-27 | criteria provided, single submitter | clinical testing |